This is in line with a study of MCF7 breast cancer SP cells which also showed a reduction in ABCG2 expression and a reduction in SP numbers following TGF-β treatment, both of which were reversable on removal of exogenous TGF-β1 [11]. Here, ABCG2 is linked to breast cancer.